Thus, we have confirmed that miR-23b-3p inhibits autophagy by targeting ATG12 and HMGB2 in MDR GC cells, which suggests that miR-23b-3p may be a novel potential target for the treatment of GC. The gene discussed is HMGB2; the disease is gastric cancer.